Physician profile
Melissa E Cloonan
NPI 1871735852
$3,384.28
in general payments reported to CMS, 2019-2025
27 companies · $606 in 2025
The $606 reported for 2025 was more than what a typical Trauma Surgery provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,496 · 2020: $41.20 · 2021: $476 · 2022: $186 · 2023: $281 · 2024: $299 · 2025: $606.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,186.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $1,001.42 | 2019-2020 | |
| Acera Surgical, INC. | $342.74 | 2021-2025 | Restrata Wound Matrix |
| Pacira Pharmaceuticals Incorporated | $179.43 | 2021-2024 | Exparel |
| Innovation Technologies INC | $174.22 | 2024-2025 | Irrisept |
| Tela Bio, INC. | $159.26 | 2019-2022 | |
| Access Pro Medical, LLC | $156.08 | 2023 | Matriderm |
| Avanos Medical | $151.40 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $149.83 | 2022-2023 | Andexxa |
| Kci USA, INC. | $139.65 | 2019-2021 | |
| Heron Therapeutics, INC. | $125.59 | 2021-2022 | |
| Acell, INC. | $124.28 | 2019 | |
| Haemonetics Corporation | $120.24 | 2025 | Teg6s Hemostasis System |
| Kerecis Limited | $112.50 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Vertex Pharmaceuticals Incorporated | $102.66 | 2025 | |
| Octapharma USA, INC. | $64.97 | 2025 | Fibryga |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $45.65 | 2019 | |
| Allergan, INC. | $38.57 | 2021 | |
| Mallinckrodt Enterprises LLC | $28.80 | 2019 | |
| Bolder Surgical LLC | $28.56 | 2019-2021 | |
| Polynovo North America LLC | $23.10 | 2025 | Novosorb Btm |
| Solventum Corporation | $21.07 | 2024 | Prevena, V.A.C. Veraflo |
| Ethicon US, LLC | $19.30 | 2019 | |
| Integra Lifesciences Corporation | $18.62 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Shire North American Group INC | $16.08 | 2019 | |
| Medtronic, INC. | $14.57 | 2025 | Ligasure |
| Medtronic USA, INC. | $13.89 | 2019 | |
| Davol INC. | $11.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Cloonan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.